AKLRD at OARSI 2022

Presentation of the results from the Phase 2a osteoarthritis trial of AKLRD’s lead candidate, APPA, and ALKRD’s sponsorship of OARSI’s Rising Star Awards are two of the reasons AKLRD’s representatives are delighted to be attending OARSI 2022.

It is the first time in 2 years that it has been possible to attend, in person, this key congress focused exclusively on osteoarthritis. More information will be released at the start of the congress.